Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Jervois Global Ord Shs V.JRV

Alternate Symbol(s):  JRVMF

Jervois Global Limited is an Australia-based supplier of cobalt and nickel, serving both the battery and chemicals markets. The Company's segments include Australia, Brazil, Finland, United States and Other. The Australia segment includes Nico Young and other Australian tenement licenses held. The Brazil segment includes the Sao Miguel Paulista nickel and cobalt refinery (SMP Refinery). The Finland segment includes the cobalt refining and specialty products business located in Kokkola, Finland. Its product categories include chemical and catalysts, pigments, powder metallurgy and battery. The United States segment includes the Idaho Cobalt Operations (ICO) cobalt-copper-gold mine in Lemhi County outside of the town of Salmon, Idaho. The Other segment consists of non-core exploration not related to Australia and the United States. The Company's non-core assets are located in Canada (Virgin River project and Kernahan/Bell project) and Australia (Arunta West project).


TSXV:JRV - Post by User

Comment by learning123456on Nov 16, 2021 5:25pm
71 Views
Post# 34133914

RE:RE:RE:RE:Interesting

RE:RE:RE:RE:InterestingZackra,

Is he saying those over 18 would benefit from the vaccine?

"Malone also said he has "a bias that the benefits probably don't outweigh the risks" for younger people who are being encouraged or required to take the vaccine.

"I can say that the risk-benefit ratio for those 18 and below doesn't justify vaccines, and there's a pretty good chance that it doesn't justify vaccination in these very young adults," he added."

<< Previous
Bullboard Posts
Next >>